As members of the Beneluxa Initiative, Ireland, Belgium and the Netherlands, have successfully concluded joint pricing negotiations for Libmeldy, a treatment designed for Metachromatic Leukodystrophy (MLD), having arrived at a mutually agreeable pricing arrangement with the...